Giant Cell Arteritis Treatment With Ultra-short Glucocorticoids and Tocilizumab
Clinical trial NCT03745586 · COMPLETED
Trial details
- NCT number
- NCT03745586
- Sponsor
- Insel Gruppe AG, University Hospital Bern
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-01
- Primary completion
- 2020-11-30
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.